Regeneron Pharmaceuticals, Inc.
REGN
Revenue
3.88B
▲130.00M▲3.46%
3 Months ChangeAssets
40.56B
▲389.30M▲0.9691%
3 Months ChangeLiabilities
9.30B
▲90.20M▲0.9792%
3 Months ChangeFree Cash Flow
815.80M
▼-562.80M▼-40.82%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-30
Form 8-K
ID: 0000872589-26-000004
2026-01-12
Form 8-K
ID: 0001104659-26-002691
2025-10-28
Form 10-Q
ID: 0000872589-25-000028
2025-10-28
Form 8-K
ID: 0000872589-25-000026
2025-10-06
Form 8-K
ID: 0001104659-25-096921
2025-08-01
Form 10-Q
ID: 0000872589-25-000019
2025-08-01
Form 8-K
ID: 0000872589-25-000017
2025-06-18
Form 8-K
ID: 0001104659-25-060637
2025-04-29
Form 10-Q
ID: 0001804220-25-000022
2025-04-29
Form 8-K
ID: 0001804220-25-000020